BCA
TEVA icon

Berman Capital Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Berman Capital Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4K Sell
476
-10
-2% -$94 ﹤0.01% 1512
2021
Q2 		$4K Hold
486
– – ﹤0.01% 1427
2021
Q1 		$5K Sell
486
-135
-22% -$1.55K ﹤0.01% 1292
2020
Q4 		$5K Buy
621
+175
+39% +$1.68K ﹤0.01% 1175
2020
Q3 		$4K Sell
446
-22
-5% -$233 ﹤0.01% 1141
2020
Q2 		$5K Sell
468
-1,321
-74% -$14.9K ﹤0.01% 998
2020
Q1 		$15K Buy
1,789
+1,427
+394% +$14.6K ﹤0.01% 570
2019
Q4 		$3K Sell
362
-45
-11% -$402 ﹤0.01% 1135
2019
Q3 		$2K Buy
407
+362
+804% +$2.77K ﹤0.01% 1232
2019
Q2 		$0 Sell
45
-39
-46% -$470 ﹤0.01% 1569
2019
Q1 		$1K Sell
84
-11
-12% -$194 ﹤0.01% 1266
2018
Q4 		$1K Buy
+95
New +$1.95K ﹤0.01% 1065

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Berman Capital Advisors's TEVA Position: Q3 2021 in Review

Berman Capital Advisors reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.1% in Q3 2021, selling an estimated $94 and leaving 476 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Berman Capital Advisors first reported a position in TEVA in Q4 2018 and has held it in 12 quarters since. The position peaked at $15K in Q1 2020. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Berman Capital Advisors held 476 shares of Teva Pharmaceutical Industries Limited worth $4K as of Q3 2021.
  • Berman Capital Advisors sold 10 Teva Pharmaceutical Industries Limited shares in Q3 2021, an estimated $94.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1512 holding.
  • Berman Capital Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's Teva Pharmaceutical Industries Limited position peaked at $15K in Q1 2020.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.